ø ٷ ּ. εԴϴ.
39 Ѿȸ мȸ ȳ
2000.06.13 - 2000.06.14
۾
÷

: 2013 6 13() ~ 14()

: Եȣ, (Ұ) Crystal Ballroom

Ȩ : http://www.cancer.or.kr/abstract/

α׷: 

Young Investigator Symposium

09:00~10:10

Session 1

Room A

1) A Few Control the Whole: How an Expression Signature from the Tumor Initiating Cell Population in Sarcoma Predicts Clinical Outcome

Ilkyu Han (Seoul National University Hospital)

2) Role of Pyknon, Long Noncoding RNA, in Gastrointestinal Cancer

Sang Kil Lee (Yonsei University College of Medicine)

3) Copy Number Alternation in Digestive Track and Gastric Adenocarcinoma

Byoungyong Shim (St. Vincents Hospital, The Catholic University)

4) Heat Shock Protein 90 Inhibitors: Is This Promising?

Dae Ho Lee (Univ. of Ulsan College of Medicine, Asan Medical Center)

Session 2

Room B

1) Prevention-oriented Clinical Trial

Sue K. Park (Seoul National University College of Medicine)

2) Supportive Care in Oncology

Jung Hye Kwon (Hallym University, Kangdong Sacred Heart Hospital)

3) Clinical Research in Palliative Care

Jung Hun Kang (Gyeongsang University Hospital)

Session 3

Room C

1) Expression of Phospho-AMPK and Insulin Receptor in Patients with NSCLC

Jin-Soo Kim (Boramae Medical Center)

2) New Conversing Technology; Plasma Medicine

Chul-Ho Kim (Ajou University School of Medicine)

3) Myeloid Cells Promote Tumor Recurrence after Radiotherapy

G-One Ahn (Pohang University of Science and Technology)

Plenary Lecture 1

10:30~11:10, Room A ~ C

Chromatin Dynamics and Epigenetic Reprogramming in Cancer

Sung Hee Baek, Ph.D. (School of Biological Sciences, Seoul National University)

Plenary Lecture 2

11:10~12:00, Room A ~ C

T Cell Stemness and Cancer Stemness

Weiping Zou, MD, Ph.D. (University of Michigan School of Medicine, USA)

Symposium 1

13:20~15:10, Room A

Angiogenesis and Circulating Tumor Cell

1) New VEGFR-2 Antagonist VSRC5 for Anti-angiogenesis Therapy

Young-Myeong Kim (Kangwon National University School of Medicine)

2) Angiogenesis and Normalization of Tumor Blood Vessels

Young-Guen Kwon (Yonsei University)

3) Circulating Tumor Cell in Clinic and Cancer Research

Jhingook Kim (Samsung Medical Center)

4) PLS3 is a Novel Marker for Circulating Colorectal Cancer Cells

Masaki Mori, M.D. (Osaka University, Japan)

Symposium 2

15:30~17:30, Room A

Molecular Pathology in Clinical Practice and Research

Joint Symposium (Korean Cancer Association and Korean Society of Pathologists)

1) Molecular Diagnosis of Lung Cancer

Jin Haeng Chung (Seoul National University Bundang Hospital)

2) Her-2 Amplification in Breast and Gastric Cancer

Young Kyung Bae (Yeung Nam University College of Medicine)

3) Molecular Diagnosis of Gastric Cancer

Do Youn Park (Pusan National University School of Medicine)

4) Molecular Diagnosis of Thyroid Cancer

Tae Sook Hwang (Konkuk University Medical Center)

5) Molecular Diagnosis of Colon Cancer

Jae Hyuk Lee (Chonnam National University Medical School)

Symposium 3

13:20~15:10, Room C

Oncogenomics: How to Translate?

Joint Symposium (Korean Cancer Association and Korean Genome Organization)

1) Clinical Application of Personal Cancer Genome Data

Se-Hoon Lee (Seoul National University College of Medicine)

2) Genome-wide Screening of Microsatellite Instability in Human Colorectal and Endometrial Cancer Genomes

Tae-Min Kim (The Catholic University of Korea School of Medicine)

3) Functional Regulatory Element Detected by Epigenetic Changes in Breast Cancer Cells

Tae-Young Roh (Pohang University of Science and Technology)

4) Integration of Cancer Genome Data and Their Clinical Application

Jongsun Jung (Syntekabio, Inc)

Symposium 4

15:30~17:30, Room C

Systems Biology in Cancer Research: Beginning of the Personalized Medicine

1) Integromics for Liver Cancer

Hyun Goo Woo (Ajou University School of Medicine)

2) Quantitative Proteomic Screening Identifies Phosphorylation of MIG6 as a key Regulatory Mechanism for Inhibitory Effect on NSCLC-derived mutant EGFR

Jeonghee Cho (Samsung Genome Institute, Samsung Medical Center)

3) Prognostic Gene Expression Signature of Colorectal Cancer

Sang Cheul Oh (Korea University Guro Hospital)

4) Development of Cancer Subtypes in Large-scale Genomics Data

In-Sun Chu (Korea Research Institute of Bioscience & Biotechnology)

International Session (Oral Presentation)

13:20~17:30, Room D, E

Luncheon Symposium 1

12:00~13:00, Room A ~ C

Palliative Care: Multi-disciplinary Approach for QoL of Cancer Patients

 

 

Educational Session

09:00~10:10

1. Innovative Treatment

Room A

1) Innovative Treatment in Urologic Malignancies

Jae Lyun Lee (Univ. of Ulsan College of Medicine, Asan Medical Center)

2) Innovative Treatment in Hematologic Malignancies

Chul Won Jung (Sungkyunkwan University School of Medicine, Samsung Medical Center)

3) Tailored Management of Metastatic Breast Cancer Based on Molecular Subtypes

Seock Ah Im (Seoul National University College of Medicine)

2. Short Course Stereotactic Body Radiotherapy (SBRT) for Oligometastases

Room B

1) SBRT Role for Oligometastases : Expected Survival Benefit

Mi-Sook Kim (Korea Institute Radiological & Medical Sciences)

2) Liver & Lung Oligometastases : SBRT vs Surgery

Woo Chul Kim (Inha University Hospital)

3) Bone Oligometastases : Role of SBRT

Jin Ho Kim (Seoul National University Hospital Integrated Cancer Care Center)

3. Clinical Trials in Surgical Oncology

Room C

1) How to Design Clinical Trial in Surgical Oncology?

Young-Woo Kim (National Cancer Center)

2) How to Standardize and Overcome Variation of Surgical Treatment?

Jin-Young Jang (Seoul National University College of Medicine)

3) Role of the Surgeon in an Oncology Trial

Gyu Seog Choi (Kyungpook National University Medical Center)

Plenary Lecture 3

10:30~11:10, Room A ~ C

Linking "Novel Target Discovery" to Clinic and Pharma

Sung Hoon Kim, Ph.D. (Biopharmaceutical Sciences College of Pharmacy, Seoul National University)

Plenary Lecture 4

11:10~12:00, Room A ~ C

Novel Therapeutic Strategies for Cancer Stem Cells

Hideyuki Saya, M.D. (School of Medicine, Keio University, Japan)

Symposium 5

13:50~15:30, Room A

Successful Cooperation between Pharmaceutical & Clinical Researchers in Oncology Drug R&D

Joint Symposium (Korean Cancer Association and National OncoVenture)

1) Clinicians Role in the Development of New Anticancer Agents

Jung-Yong Kim (National OncoVenture)

2) Innovative Target Discovery for Therapeutic Antibody

Youngwoo Park (Korea Research Institute of Bioscience & Biotechnology)

3) Open Innovation and Clinical Development of a Novel Pan-Her Inhibitor Poziotinib

Jee Woong Son (Vice President of Hanmi Pharm)

4) Best Development of Cancer Drug by Translating Biologic Discovery into Clinical Trials

Ji-Youn Han (National Cancer Center)

Symposium 6

15:50~17:30, Room A

Issues in Conducting Clinical Trials between the Cooperative Groups

1) Hurdles and Issues for Conducting Collabolative Clinical Trials with EORTC

Hwan Jung Yun (Chungnam National University School of Medicine)

2) Experiences of KGOG in Conducting Clinical Trials of GOG and GCIG

Jae Hoon Kim (Yonsei University College of Medicine)

3) KCSG Experience in International Collaboration - Challenges and Opportunities

Jee Hyun Kim (Seoul National University Bundang Hospital)

4) Collaboration between KROG and RTOG

Kwan Ho Cho (National Cancer Center)

Symposium 7

13:50~15:30, Room C

Molecular Imaging for Theragnostics

1) Molecular Imaging for Surgical Resection of Cancer

Hyun Koo Kim (Korea University College of Medicine)

2) Programming of Bacteria for Cancer Theragnostics

Jung-Joon Min (Chonnam National University Medical School)

3) Radio-theragnostics for Tumor Angiogenesis in a Tumor-bearing Mouse Model and a Pilot Study in Human Patients

Byung Chul Lee (Seoul National University Bundang Hospital)

4) Molecular Imaging for Personalized Theragnostics

Mei Tian, M.D., Ph.D. (Zhejiang University School of Medicine, China)

Symposium 8

15:50~17:30, Room C

Cancer Metabolism

1) Targeting Arginine-dependent Cancers with Pegylated Arginine Deiminase

Peter Szlosarek, Ph.D.
(Barts Cancer Institute - a Cancer Research UK Centre of Excellence, Queen Mary, University of London, UK)

2) Metabolic Remodelling in Papillary Thyroid Cancer

Minho Shong (Chungnam National University School of Medicine)

3) Diagnosis of Cancer Using Metabolomics Method

Seung Hong Choi (Seoul National University College of Medicine)

4) Effect of Metformin for Breast Cancer

Wonshik Han (Seoul National University College of Medicine)

Symposium 9

13:50~15:30, Room E

Current Standard and Future Perspectives in Gynecologic Cancer

Joint Symposium (Korean Cancer Association and Korean Society of Gynecologic Oncology)

1) Cervical Cancer Screening Paradigm Shift is Possible? From Cytology to HPV Molecular Diagnostics

Jae-Kwan Lee (Korea University Guro Hospital)

2) Improving Ovarian Cancer Screening with Novel Biomarker Algorithm

Yong Man Kim (Univ. of Ulsan College of Medicine, Asan Medical Center)

3) Current Clinical Evidence & Future Direction of Molecular Target Therapy in Epithelial Ovarian Cancer

Jae Weon Kim (Seoul National University College of Medicine)

4) Retroperitoneal Lymphadnectomy Can be Safely Omitted in Selected Early Stage Endometrial Cancer

Sokbom Kang (National Cancer Center)

Symposium 10

15:50~17:30, Room E

Research, Clinical Practice and Policy for Cancer Survivorship

1) Updates in Cancer Survivorship Research

Dae Ho Lee (Univ. of Ulsan College of Medicine, Asan Medical Center)

2) Updates in Cancer Survivorship Clinical Practice

Myong Cheol Lim (National Cancer Center)

3) Research for Cancer Survivorship Health Management in Oncology Nursing Priorities for Research and Development in Oncology Nursing Service

Eui Geum Oh (College of Nursing, Yonsei University)

4) Framework for Translating Cancer Survivorship Research into Clinical Practice and Policy

Young Ho Yun (Seoul National University Hospital Integrated Cancer Care Center)

Luncheon Symposium 2

12:00~13:00, Room A ~ C

Anti-angiogenic Drugs for Colorectal Cancer: Exploring New Possibilities

Napoleone Ferrara, M.D. (Moores Cancer Center, University of California, USA)


Young Investigator Symposium 09:00~10:10
Session 1 Room A
1) A Few Control the Whole: How an Expression Signature from the Tumor Initiating Cell Population in Sarcoma Predicts Clinical Outcome
Ilkyu Han (Seoul National University Hospital)
2) Role of Pyknon, Long Noncoding RNA, in Gastrointestinal Cancer
Sang Kil Lee (Yonsei University College of Medicine)
3) Copy Number Alternation in Digestive Track and Gastric Adenocarcinoma
Byoungyong Shim (St. Vincents Hospital, The Catholic University)
4) Heat Shock Protein 90 Inhibitors: Is This Promising?
Dae Ho Lee (Univ. of Ulsan College of Medicine, Asan Medical Center)
Session 2 Room B
1) Prevention-oriented Clinical Trial
Sue K. Park (Seoul National University College of Medicine)
2) Supportive Care in Oncology
Jung Hye Kwon (Hallym University, Kangdong Sacred Heart Hospital)
3) Clinical Research in Palliative Care
Jung Hun Kang (Gyeongsang University Hospital)
Session 3 Room C
1) Expression of Phospho-AMPK and Insulin Receptor in Patients with NSCLC
Jin-Soo Kim (Boramae Medical Center)
2) New Conversing Technology; Plasma Medicine
Chul-Ho Kim (Ajou University School of Medicine)
3) Myeloid Cells Promote Tumor Recurrence after Radiotherapy
G-One Ahn (Pohang University of Science and Technology)
Plenary Lecture 1 10:30~11:10, Room A ~ C
Chromatin Dynamics and Epigenetic Reprogramming in Cancer
Sung Hee Baek, Ph.D. (School of Biological Sciences, Seoul National University)
Plenary Lecture 2 11:10~12:00, Room A ~ C
T Cell Stemness and Cancer Stemness
Weiping Zou, MD, Ph.D. (University of Michigan School of Medicine, USA)
Symposium 1 13:20~15:10, Room A
Angiogenesis and Circulating Tumor Cell
1) New VEGFR-2 Antagonist VSRC5 for Anti-angiogenesis Therapy
Young-Myeong Kim (Kangwon National University School of Medicine)
2) Angiogenesis and Normalization of Tumor Blood Vessels
Young-Guen Kwon (Yonsei University)
3) Circulating Tumor Cell in Clinic and Cancer Research
Jhingook Kim (Samsung Medical Center)
4) PLS3 is a Novel Marker for Circulating Colorectal Cancer Cells
Masaki Mori, M.D. (Osaka University, Japan)
Symposium 2 15:30~17:30, Room A
Molecular Pathology in Clinical Practice and Research
Joint Symposium (Korean Cancer Association and Korean Society of Pathologists)
1) Molecular Diagnosis of Lung Cancer
Jin Haeng Chung (Seoul National University Bundang Hospital)
2) Her-2 Amplification in Breast and Gastric Cancer
Young Kyung Bae (Yeung Nam University College of Medicine)
3) Molecular Diagnosis of Gastric Cancer
Do Youn Park (Pusan National University School of Medicine)
4) Molecular Diagnosis of Thyroid Cancer
Tae Sook Hwang (Konkuk University Medical Center)
5) Molecular Diagnosis of Colon Cancer
Jae Hyuk Lee (Chonnam National University Medical School)
Symposium 3 13:20~15:10, Room C
Oncogenomics: How to Translate?
Joint Symposium (Korean Cancer Association and Korean Genome Organization)
1) Clinical Application of Personal Cancer Genome Data
Se-Hoon Lee (Seoul National University College of Medicine)
2) Genome-wide Screening of Microsatellite Instability in Human Colorectal and Endometrial Cancer Genomes
Tae-Min Kim (The Catholic University of Korea School of Medicine)
3) Functional Regulatory Element Detected by Epigenetic Changes in Breast Cancer Cells
Tae-Young Roh (Pohang University of Science and Technology)
4) Integration of Cancer Genome Data and Their Clinical Application
Jongsun Jung (Syntekabio, Inc)
Symposium 4 15:30~17:30, Room C
Systems Biology in Cancer Research: Beginning of the Personalized Medicine
1) Integromics for Liver Cancer
Hyun Goo Woo (Ajou University School of Medicine)
2) Quantitative Proteomic Screening Identifies Phosphorylation of MIG6 as a key Regulatory Mechanism for Inhibitory Effect on NSCLC-derived mutant EGFR
Jeonghee Cho (Samsung Genome Institute, Samsung Medical Center)
3) Prognostic Gene Expression Signature of Colorectal Cancer
Sang Cheul Oh (Korea University Guro Hospital)
4) Development of Cancer Subtypes in Large-scale Genomics Data
In-Sun Chu (Korea Research Institute of Bioscience & Biotechnology)
International Session (Oral Presentation) 13:20~17:30, Room D, E
Luncheon Symposium 1 12:00~13:00, Room A ~ C
Palliative Care: Multi-disciplinary Approach for QoL of Cancer Patients



Educational Session 09:00~10:10
1. Innovative Treatment Room A
1) Innovative Treatment in Urologic Malignancies
Jae Lyun Lee (Univ. of Ulsan College of Medicine, Asan Medical Center)
2) Innovative Treatment in Hematologic Malignancies
Chul Won Jung (Sungkyunkwan University School of Medicine, Samsung Medical Center)
3) Tailored Management of Metastatic Breast Cancer Based on Molecular Subtypes
Seock Ah Im (Seoul National University College of Medicine)
2. Short Course Stereotactic Body Radiotherapy (SBRT) for Oligometastases Room B
1) SBRT Role for Oligometastases : Expected Survival Benefit
Mi-Sook Kim (Korea Institute Radiological & Medical Sciences)
2) Liver & Lung Oligometastases : SBRT vs Surgery
Woo Chul Kim (Inha University Hospital)
3) Bone Oligometastases : Role of SBRT
Jin Ho Kim (Seoul National University Hospital Integrated Cancer Care Center)
3. Clinical Trials in Surgical Oncology Room C
1) How to Design Clinical Trial in Surgical Oncology?
Young-Woo Kim (National Cancer Center)
2) How to Standardize and Overcome Variation of Surgical Treatment?
Jin-Young Jang (Seoul National University College of Medicine)
3) Role of the Surgeon in an Oncology Trial
Gyu Seog Choi (Kyungpook National University Medical Center)
Plenary Lecture 3 10:30~11:10, Room A ~ C
Linking "Novel Target Discovery" to Clinic and Pharma
Sung Hoon Kim, Ph.D. (Biopharmaceutical Sciences College of Pharmacy, Seoul National University)
Plenary Lecture 4 11:10~12:00, Room A ~ C
Novel Therapeutic Strategies for Cancer Stem Cells
Hideyuki Saya, M.D. (School of Medicine, Keio University, Japan)
Symposium 5 13:50~15:30, Room A
Successful Cooperation between Pharmaceutical & Clinical Researchers in Oncology Drug R&D
Joint Symposium (Korean Cancer Association and National OncoVenture)
1) Clinicians Role in the Development of New Anticancer Agents
Jung-Yong Kim (National OncoVenture)
2) Innovative Target Discovery for Therapeutic Antibody
Youngwoo Park (Korea Research Institute of Bioscience & Biotechnology)
3) Open Innovation and Clinical Development of a Novel Pan-Her Inhibitor Poziotinib
Jee Woong Son (Vice President of Hanmi Pharm)
4) Best Development of Cancer Drug by Translating Biologic Discovery into Clinical Trials
Ji-Youn Han (National Cancer Center)
Symposium 6 15:50~17:30, Room A
Issues in Conducting Clinical Trials between the Cooperative Groups
1) Hurdles and Issues for Conducting Collabolative Clinical Trials with EORTC
Hwan Jung Yun (Chungnam National University School of Medicine)
2) Experiences of KGOG in Conducting Clinical Trials of GOG and GCIG
Jae Hoon Kim (Yonsei University College of Medicine)
3) KCSG Experience in International Collaboration - Challenges and Opportunities
Jee Hyun Kim (Seoul National University Bundang Hospital)
4) Collaboration between KROG and RTOG
Kwan Ho Cho (National Cancer Center)
Symposium 7 13:50~15:30, Room C
Molecular Imaging for Theragnostics
1) Molecular Imaging for Surgical Resection of Cancer
Hyun Koo Kim (Korea University College of Medicine)
2) Programming of Bacteria for Cancer Theragnostics
Jung-Joon Min (Chonnam National University Medical School)
3) Radio-theragnostics for Tumor Angiogenesis in a Tumor-bearing Mouse Model and a Pilot Study in Human Patients
Byung Chul Lee (Seoul National University Bundang Hospital)
4) Molecular Imaging for Personalized Theragnostics
Mei Tian, M.D., Ph.D. (Zhejiang University School of Medicine, China)
Symposium 8 15:50~17:30, Room C
Cancer Metabolism
1) Targeting Arginine-dependent Cancers with Pegylated Arginine Deiminase
Peter Szlosarek, Ph.D.
(Barts Cancer Institute - a Cancer Research UK Centre of Excellence, Queen Mary, University of London, UK)
2) Metabolic Remodelling in Papillary Thyroid Cancer
Minho Shong (Chungnam National University School of Medicine)
3) Diagnosis of Cancer Using Metabolomics Method
Seung Hong Choi (Seoul National University College of Medicine)
4) Effect of Metformin for Breast Cancer
Wonshik Han (Seoul National University College of Medicine)
Symposium 9 13:50~15:30, Room E
Current Standard and Future Perspectives in Gynecologic Cancer
Joint Symposium (Korean Cancer Association and Korean Society of Gynecologic Oncology)
1) Cervical Cancer Screening Paradigm Shift is Possible? From Cytology to HPV Molecular Diagnostics
Jae-Kwan Lee (Korea University Guro Hospital)
2) Improving Ovarian Cancer Screening with Novel Biomarker Algorithm
Yong Man Kim (Univ. of Ulsan College of Medicine, Asan Medical Center)
3) Current Clinical Evidence & Future Direction of Molecular Target Therapy in Epithelial Ovarian Cancer
Jae Weon Kim (Seoul National University College of Medicine)
4) Retroperitoneal Lymphadnectomy Can be Safely Omitted in Selected Early Stage Endometrial Cancer
Sokbom Kang (National Cancer Center)
Symposium 10 15:50~17:30, Room E
Research, Clinical Practice and Policy for Cancer Survivorship
1) Updates in Cancer Survivorship Research
Dae Ho Lee (Univ. of Ulsan College of Medicine, Asan Medical Center)
2) Updates in Cancer Survivorship Clinical Practice
Myong Cheol Lim (National Cancer Center)
3) Research for Cancer Survivorship Health Management in Oncology Nursing Priorities for Research and Development in Oncology Nursing Service
Eui Geum Oh (College of Nursing, Yonsei University)
4) Framework for Translating Cancer Survivorship Research into Clinical Practice and Policy
Young Ho Yun (Seoul National University Hospital Integrated Cancer Care Center)
Luncheon Symposium 2 12:00~13:00, Room A ~ C
Anti-angiogenic Drugs for Colorectal Cancer: Exploring New Possibilities
Napoleone Ferrara, M.D. (Moores Cancer Center, University of California, USA)

 

 

 


2013-04-09 3:17:46, ȸ : 1422